Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1980 Feb;39(2):403–410.

Expression of blood group-like antigens on the T lymphocytes of acute leukaemia patients in remission.

S Pullen, P Hersey
PMCID: PMC1538051  PMID: 6966993

Abstract

A number of previous studies have described antibodies in normal sera reactive to human leukaemia cells. In the course of studies on humoral immunity to acute myeloid leukaemia (AML) cells it was noticed that sera from normal subjects were cytotoxic in complement lysis and leucocyte dependent antibody (LDA) assays to blood leucocytes from patients with AML in remission. Investigation of these reactions in eleven patients with acute leukaemia in complete or partial remission revealed that reactivity occurred most frequently between sera from normal blood group O or B subjects and leucocytes from patients of blood group A (five patients). Leucocytes from blood group O patients were largely unreactive. Blood leucocytes from five of six patients in relapse did not react with normal sera. Subsequent studies revealed that the antigens were detected only on T lymphocytes. Reactivity could be removed by absorption on red cells of blood group A but not sheep or Ox red blood cells suggesting the antigens concerned were closely related to blood group A antigens. Some reactivity with antisera to the blood group H antigens was also evident in these studies. Gel filtration studies indicated that lymphocyte dependent antibody mediated cytotoxicity was mediated by IgG antibodies while complement dependent lysis was mainly mediated by IgM antibodies. The biological significance of these findings has yet to be determined but these results suggest that reactivity with blood group antigens needs to be considered in in vitro cytotoxicity studies involving leucocytes from leukaemia patients.

Full text

PDF
403

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON R. E., WALFORD R. L. DIRECT DEMONSTARTION OF A, B, AND RH DEGREES (D) BLOOD GROUP ANTIGENS ON HUMAN LEUKOCYTES. Am J Clin Pathol. 1963 Sep;40:239–242. doi: 10.1093/ajcp/40.3.239. [DOI] [PubMed] [Google Scholar]
  2. Bias W. B., Santos G. W., Burke P. J., Mullins G. M., Humphrey R. L. Cytotoxic antibody in normal human serums reactive with tumor cells from acute lymphocytic leukemia. Science. 1972 Oct 20;178(4058):304–306. doi: 10.1126/science.178.4058.304. [DOI] [PubMed] [Google Scholar]
  3. Dore J. F., Guibout C., Bertoglio J., Liabeuf A. Cytotoxic antibodies to human leukaemia cells in normal human sera. Biomedicine. 1976 Dec 30;25(10):382–384. [PubMed] [Google Scholar]
  4. Dore J. F., Motta R., Marholev L., Hrsak I., Colas de la Noue H., Seman G., De Vassal F., Mathé G. New antigens in human leukaemic cells and antibody in the serum of leukaemic patients. Lancet. 1967 Dec 30;2(7531):1396–1398. doi: 10.1016/s0140-6736(67)93027-9. [DOI] [PubMed] [Google Scholar]
  5. Flory L. L. A and H antigens on leucocytes. Vox Sang. 1967 Oct;13(4):362–365. doi: 10.1111/j.1423-0410.1967.tb03121.x. [DOI] [PubMed] [Google Scholar]
  6. Fäldt R., Ankerst J. Tumor-associated humoral cytotoxicity in patients with acute myelogenous leukemia before and after chemotherapy. Int J Cancer. 1977 Dec 15;20(6):824–833. doi: 10.1002/ijc.2910200603. [DOI] [PubMed] [Google Scholar]
  7. Hakomori S. I., Koscielak J., Bloch K. J., Jeanloz R. W. Immunologic relationship between blood group substances and a fucose-containing glycolipid of human adenocarcinoma. J Immunol. 1967 Jan;98(1):31–38. [PubMed] [Google Scholar]
  8. Hakomori S., Wang S. M., Young W. W., Jr Isoantigenic expression of Forssman glycolipid in human gastric and colonic mucosa: its possible identity with "A-like antigen" in human cancer. Proc Natl Acad Sci U S A. 1977 Jul;74(7):3023–3027. doi: 10.1073/pnas.74.7.3023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hersey P., Edwards A., Edwards J., Adams E., Milton G. W., Nelson D. S. Specificity of cell-mediated cytotoxicity against human melanoma lines: evidence for "non-specific" killing by activated T-cells. Int J Cancer. 1975 Jul 15;16(1):173–183. doi: 10.1002/ijc.2910160119. [DOI] [PubMed] [Google Scholar]
  10. Hersey P., Edwards A., Edwards J. Characterization of mononuclear effector cells in human blood. Clin Exp Immunol. 1976 Jan;23(1):104–113. [PMC free article] [PubMed] [Google Scholar]
  11. Hersey P., MacLennan I. C., Campbell A. C., Harris R., Freeman C. B. Cytotoxicity against human leukaemic cells. I. Demonstration of antibody-dependent lymphocyte killing of human allogeneic myeloblasts. Clin Exp Immunol. 1973 Jun;14(2):159–167. [PMC free article] [PubMed] [Google Scholar]
  12. Jose D. G., Ekert H., Colebatch J., Waters K., Wilson F., O'Keefe D. Immune function at diagnosis in relation to responses to therapy in acute lymphocytic leukemia of childhood. Blood. 1976 Jun;47(6):1011–1021. [PubMed] [Google Scholar]
  13. Kaplan M. E., Clark C. An improved rosetting assay for detection of human T lymphocytes. J Immunol Methods. 1974 Jul;5(2):131–135. doi: 10.1016/0022-1759(74)90003-9. [DOI] [PubMed] [Google Scholar]
  14. Levine P. Blood group and tissue genetic markers in familial adenocarcinoma: potential specific immunotherapy. Semin Oncol. 1978 Mar;5(1):25–34. [PubMed] [Google Scholar]
  15. Mann D. L., Leventhal B., Halterman R. Human antisera detecting leukemia-associated antigens on autochthonous tumor cells. J Natl Cancer Inst. 1975 Feb;54(2):345–347. [PubMed] [Google Scholar]
  16. Mogensen C. E. The glomerular permeability determined by dextran clearance using Sephadex gel filtration. Scand J Clin Lab Invest. 1968;21(1):77–82. doi: 10.3109/00365516809076979. [DOI] [PubMed] [Google Scholar]
  17. Moore J. O., Logue G. L. I and i antigens on normal and leukemic leukocytes. Cancer. 1978 Jul;42(1):140–148. doi: 10.1002/1097-0142(197807)42:1<140::aid-cncr2820420124>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  18. Murray E., McCarthy W. H., Hersey P. Blocking factors against leucocyte-dependent melanoma antibody in the sera of melanoma patients. Br J Cancer. 1977 Jul;36(1):7–14. doi: 10.1038/bjc.1977.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Schacter B., Bias W. B., Humphrey R. L. Normal human sera cytotoxic to cells of human acute leukemia. Tissue Antigens. 1976 Nov;8(5):289–298. doi: 10.1111/j.1399-0039.1976.tb00581.x. [DOI] [PubMed] [Google Scholar]
  20. Springer G. F., Desai P. R., Scanlon E. F. Blood group MN precursors as human breast carcinoma-associated antigens and "naturally" occurring human cytotoxins against them. Cancer. 1976 Jan;37(1):169–176. doi: 10.1002/1097-0142(197601)37:1<169::aid-cncr2820370124>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  21. Yoshida T. O., Imai K. Auto-antibody to human leukemic cell membrane as detected by immune adherence. Rev Eur Etud Clin Biol. 1970 Jan;15(1):61–65. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES